Haemonetics Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 27, 2025	Mar '25 Mar 29, 2025	Mar '24 Mar 30, 2024	Apr '23 Apr 1, 2023	Apr '22 Apr 2, 2022	Apr '21 Apr 3, 2021
Revenue	1,318	1,361	1,309	1,169	993.2	870.46
Revenue Growth (YoY)	-4.02%	3.96%	12.01%	17.67%	14.10%	-11.94%
Cost of Revenue	524.5	582.28	597.14	545.79	462.43	442.02
Gross Profit	793.78	778.55	711.92	622.87	530.77	428.45
Selling, General & Admin	428.89	422.05	420.82	373.95	332.2	263.83
Research & Development	61.09	61.13	52.23	49.08	45.98	31.69
Amortization of Goodwill & Intangibles	44.8	48.26	32.03	32.64	47.41	32.83
Operating Expenses	534.78	531.45	505.08	455.67	425.6	328.35
Operating Income	259	247.1	206.84	167.2	105.17	100.1
Interest Expense	-48.7	-35.9	-19.5	-13	-5.8	-9.4
Currency Exchange Gain (Loss)	-7.43	-1.53	-	-	-	-
Other Non Operating Income (Expenses)	32.21	15.09	6.48	-1.63	-11.32	-4.43
EBT Excluding Unusual Items	235.07	224.75	193.82	152.57	88.05	86.26
Merger & Restructuring Charges	-21.63	-45.91	-33.54	-11.55	-28.82	-25.26
Gain (Loss) on Sale of Assets	-	-	2	0.38	9.6	32.81
Asset Writedown	-9.3	-2.39	-10.42	-	-5.2	-20.9
Other Unusual Items	23.02	35.62	-	-	-	-
Pretax Income	227.17	212.07	151.87	141.4	63.63	72.91
Income Tax Expense	51.73	44.39	34.31	26	20.25	-6.56
Net Income	175.44	167.68	117.56	115.4	43.38	79.47
Net Income to Common	175.44	167.68	117.56	115.4	43.38	79.47
Net Income Growth	34.88%	42.63%	1.87%	166.05%	-45.42%	3.85%
Shares Outstanding (Basic)	48	50	51	51	51	51
Shares Outstanding (Diluted)	48	51	51	51	51	51
Shares Change (YoY)	-6.04%	-1.30%	-0.04%	0.13%	0.12%	-1.01%
EPS (Basic)	3.66	3.33	2.32	2.27	0.85	1.57
EPS (Diluted)	3.65	3.31	2.29	2.24	0.84	1.55
EPS Growth	43.84%	44.54%	2.23%	166.67%	-45.81%	4.73%
Free Cash Flow	308.08	142.45	143.63	81.73	75.75	71.77
Free Cash Flow Per Share	6.40	2.81	2.79	1.59	1.48	1.40
Gross Margin	60.21%	57.21%	54.38%	53.30%	53.44%	49.22%
Operating Margin	19.65%	18.16%	15.80%	14.31%	10.59%	11.50%
Profit Margin	13.31%	12.32%	8.98%	9.88%	4.37%	9.13%
Free Cash Flow Margin	23.37%	10.47%	10.97%	6.99%	7.63%	8.24%
EBITDA	364.9	355.99	295.45	252.01	191.72	184.38
EBITDA Margin	27.68%	26.16%	22.57%	21.56%	19.30%	21.18%
D&A For EBITDA	105.91	108.89	88.62	84.81	86.55	84.29
EBIT	259	247.1	206.84	167.2	105.17	100.1
EBIT Margin	19.65%	18.16%	15.80%	14.31%	10.59%	11.50%
Effective Tax Rate	22.77%	20.93%	22.59%	18.39%	31.83%	-
Advertising Expenses	-	7.7	7.1	7.2	4.4	2.7

Updated Feb 5, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q